Terumo Completes Twentieth Case of DuraHeart Artificial Heart Implantation.Tokyo, Japan, July 25, 2005 - (JCNN JCNN Japan Corporate News Network ) - Terumo (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 4543) announced on July 22 that the twentieth DuraHeart clinical trial implant in Europe was completed on July 19. In conjunction with this achievement, the company expects that the DuraHeart will be available in Europe within fiscal 2005. The DuraHeart is a centrifugal left-ventricular assist system (LVAS LVAS Left Ventricular Assist System ) with magnetic suspension. The small-sized device offers excellent durability and helps reduce the risk of infection. With the aim of launching the DuraHeart in the US and Japan, Terumo will strive to prepare clinical trials in each country. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion